NCT03435692

Brief Summary

Hip surgery in children is painful and the optimal modality for managing post-operative pain has not been established. This prospective randomized controlled trail compares lumbar plexus catheter (LPC), lumbar epidural catheter (LEC) and continuous patient-controlled analgesia (PCA) with intravenous morphine.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2011

Typical duration for not_applicable

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 15, 2011

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 29, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 29, 2014

Completed
3.5 years until next milestone

First Submitted

Initial submission to the registry

January 30, 2018

Completed
20 days until next milestone

First Posted

Study publicly available on registry

February 19, 2018

Completed
3.7 years until next milestone

Results Posted

Study results publicly available

November 2, 2021

Completed
Last Updated

November 2, 2021

Status Verified

October 1, 2021

Enrollment Period

3 years

First QC Date

January 30, 2018

Results QC Date

March 27, 2021

Last Update Submit

October 4, 2021

Conditions

Outcome Measures

Primary Outcomes (3)

  • Hospital Length of Stay

    Total hospital length of stay

    Through hospital stay, an average of 2-3 days.

  • Maximum Pain Score

    Mean of Maximum Pain Score POD 0-2 Face, Legs, Activity, Cry, Consolability Pain Scale (FLACC) for children 1-3 years of age, Faces Pain Scale - Revised (FPS-R) for children over age 3 and the Numeric scale (0-10) for children over age 7. minimum value = 0, maximum value 10 (higher score is worse)

    Post-Operative Days 0-2

  • Total Perioperative Morphine Equivalents

    All administered opioids measured as morphine equivalents (mg/kg)

    Post-Operative Days 0-2

Secondary Outcomes (3)

  • Nausea

    Post-Operative Days 0-2

  • Itching

    Post-Operative Days 0-2

  • Muscle Spasm

    Post-Operative days 0-2

Study Arms (3)

Lumbar Plexus Catheter

EXPERIMENTAL

Children undergoing pediatric hip surgery will have a lumbar plexus catheter placed (with bolus and continuous infusion of ropivacaine) intraoperatively for perioperative pain control. An intraoperative pain protocol will dictate if the patient will receive intravenous fentanyl or morphine. Post operative side effects will be controlled with the administration of ondansetron for nausea and vomiting, diphenhydramine for itching, and lorazepam for muscle spasms. Post operative pain control will be managed with as needed (PRN) morphine and oxycodone as well as scheduled acetaminophen.

Procedure: Lumbar Plexus CatheterDrug: FentanylDrug: MorphineDrug: LorazepamDrug: OndansetronDrug: DiphenhydramineDrug: AcetaminophenDrug: OxycodoneDrug: Ropivacaine

Lumbar Epidural Catheter

ACTIVE COMPARATOR

Children undergoing pediatric hip surgery will have an epidural catheter placed (with bolus and continuous infusion of ropivacaine) intraoperatively for perioperative pain control. An intraoperative pain protocol will dictate if the patient will receive intravenous fentanyl or morphine. Post operative side effects will be controlled with the administration of ondansetron for nausea and vomiting, diphenhydramine for itching, and lorazepam for muscle spasms. Post operative pain control will be managed with as needed (PRN) morphine and oxycodone as well as scheduled acetaminophen.

Procedure: Lumbar Epidural CatheterDrug: FentanylDrug: MorphineDrug: LorazepamDrug: OndansetronDrug: DiphenhydramineDrug: AcetaminophenDrug: OxycodoneDrug: Ropivacaine

Patient Controlled Analgesia

ACTIVE COMPARATOR

Children undergoing pediatric hip surgery will have patient controlled analgesia (with morphine) started in the post anesthesia care unit for post operative pain control. An intraoperative pain protocol will dictate if the patient will receive intravenous fentanyl or morphine. Post operative side effects will be controlled with the administration of ondansetron for nausea and vomiting, diphenhydramine for itching, and lorazepam for muscle spasms. Post operative pain control will be managed with as needed (PRN) morphine and oxycodone as well as scheduled acetaminophen.

Procedure: Patient Controlled AnalgesiaDrug: FentanylDrug: MorphineDrug: LorazepamDrug: OndansetronDrug: DiphenhydramineDrug: AcetaminophenDrug: Oxycodone

Interventions

lumbar plexus catheter placed intraoperatively for perioperative pain control

Also known as: LPC
Lumbar Plexus Catheter

lumbar epidural catheter placed intraoperatively for perioperative pain control

Also known as: LEC
Lumbar Epidural Catheter

Patient Controlled Analgesia (PCA) was started post operatively for perioperative pain control

Also known as: PCA
Patient Controlled Analgesia

Intravenous fentanyl was administered in the operating room for induction of anesthesia. Subsequent doses in the operating room were standardized to be given only for heart rate or blood pressure increases \> 20% above baseline and occurring more than 30 minutes after the block if applicable.

Lumbar Epidural CatheterLumbar Plexus CatheterPatient Controlled Analgesia

In the operating room patients, intravenous morphine was administered if patients had a failed block and standardized to be given only for heart rate or blood pressure increases \> 20% above baseline and after fentanyl had been administered. Intravenous Morphine was also administered in the operating room if the patient was randomized to the Patient Controlled Analgesia (PCA) arm of the study. Post operatively intravenous Morphine was administered as needed for severe pain.

Lumbar Epidural CatheterLumbar Plexus CatheterPatient Controlled Analgesia

Intravenous Lorazepam was administered as needed for muscle spasm post operatively.

Also known as: Ativan
Lumbar Epidural CatheterLumbar Plexus CatheterPatient Controlled Analgesia

Intravenous Ondansetron was administered as needed for nausea and vomiting post operatively.

Also known as: Zofran
Lumbar Epidural CatheterLumbar Plexus CatheterPatient Controlled Analgesia

Intravenous Diphenhydramine was administered as needed for itching postoperatively.

Also known as: Benadryl
Lumbar Epidural CatheterLumbar Plexus CatheterPatient Controlled Analgesia

Oral Acetaminophen was administered as needed for pain in the Post-Anesthesia Care Unit (PACU) and then scheduled for 72 hours.

Also known as: Tylenol
Lumbar Epidural CatheterLumbar Plexus CatheterPatient Controlled Analgesia

Oral Oxycodone was administered as needed for breakthrough pain post operatively.

Lumbar Epidural CatheterLumbar Plexus CatheterPatient Controlled Analgesia

Intravenous Ropivacaine was administered as part of the initial bolus after placement of the lumbar epidural or lumbar plexus catheter and then as a continuous infusion post operatively.

Lumbar Epidural CatheterLumbar Plexus Catheter

Eligibility Criteria

Age1 Year - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Children undergoing unilateral hip surgery, including pelvic innominate osteotomies, proximal femoral osteotomies, and arthrotomies (for open reduction, loose body removal, labral debridement or labral repair).

You may not qualify if:

  • History of a previous spine surgery, spina bifida, coagulopathy, skin infection, allergies to study medications (i.e. local anesthetics and opioids), patients taking opioids at the time of enrollment and, those having concurrent procedures distal to the hip.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (5)

  • Tredwell SJ. Neonatal screening for hip joint instability. Its clinical and economic relevance. Clin Orthop Relat Res. 1992 Aug;(281):63-8.

    PMID: 1499229BACKGROUND
  • Horlocker TT, Kopp SL, Pagnano MW, Hebl JR. Analgesia for total hip and knee arthroplasty: a multimodal pathway featuring peripheral nerve block. J Am Acad Orthop Surg. 2006 Mar;14(3):126-35. doi: 10.5435/00124635-200603000-00003.

    PMID: 16520363BACKGROUND
  • Choi PT, Bhandari M, Scott J, Douketis J. Epidural analgesia for pain relief following hip or knee replacement. Cochrane Database Syst Rev. 2003;2003(3):CD003071. doi: 10.1002/14651858.CD003071.

    PMID: 12917945BACKGROUND
  • Marino J, Russo J, Kenny M, Herenstein R, Livote E, Chelly JE. Continuous lumbar plexus block for postoperative pain control after total hip arthroplasty. A randomized controlled trial. J Bone Joint Surg Am. 2009 Jan;91(1):29-37. doi: 10.2106/JBJS.H.00079.

    PMID: 19122076BACKGROUND
  • Block BM, Liu SS, Rowlingson AJ, Cowan AR, Cowan JA Jr, Wu CL. Efficacy of postoperative epidural analgesia: a meta-analysis. JAMA. 2003 Nov 12;290(18):2455-63. doi: 10.1001/jama.290.18.2455.

    PMID: 14612482BACKGROUND

MeSH Terms

Interventions

Analgesia, Patient-ControlledPassive Cutaneous AnaphylaxisFentanylMorphineLorazepamOndansetronDiphenhydramineAcetaminophenOxycodoneRopivacaine

Intervention Hierarchy (Ancestors)

AnalgesiaAnesthesia and AnalgesiaSkin TestsImmunologic TestsClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisInvestigative TechniquesImmunologic TechniquesAntigen-Antibody ReactionsImmune System PhenomenaPiperidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsMorphine DerivativesMorphinansOpiate AlkaloidsAlkaloidsHeterocyclic Compounds, Bridged-RingHeterocyclic Compounds, 4 or More RingsHeterocyclic Compounds, Fused-RingPhenanthrenesPolycyclic Aromatic HydrocarbonsPolycyclic CompoundsBenzodiazepinonesBenzodiazepinesBenzazepinesHeterocyclic Compounds, 2-RingImidazolesAzolesCarbazolesIndolesHeterocyclic Compounds, 3-RingEthylaminesAminesOrganic ChemicalsBenzhydryl CompoundsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsAcetanilidesAnilidesAmidesAniline CompoundsCodeine

Limitations and Caveats

This study was terminated early because funding was exhausted prior to enrolling intended number of patients. Based on the pre study power analysis we planned to recruit 75 patients; however, we were only able to enroll 42 patients due to limited funding.

Results Point of Contact

Title
David E. Liston, MD, MPH
Organization
Seattle Children's Hospital

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor, Attending Anesthesiologist

Study Record Dates

First Submitted

January 30, 2018

First Posted

February 19, 2018

Study Start

July 15, 2011

Primary Completion

July 29, 2014

Study Completion

July 29, 2014

Last Updated

November 2, 2021

Results First Posted

November 2, 2021

Record last verified: 2021-10

Data Sharing

IPD Sharing
Will not share